

September 2024: Obstetrics
Aug 15, 2024
Dr. Torri D. Metz, an associate professor and maternal-fetal medicine expert at the University of Utah, shares key insights on managing mild chronic hypertension during pregnancy. She discusses the benefits of elective induction at 39 weeks, emphasizing tailored delivery approaches for better maternal and fetal health. The conversation also covers innovative postpartum monitoring practices and the importance of research for improved outcomes, including findings from the significant CHAP trial on blood pressure management for pregnant individuals.
AI Snips
Chapters
Transcript
Episode notes
Radiologic Interventions For Placenta Accreta Are Uncertain
- Prophylactic radiologic interventions for placenta accreta show limited evidence but may reduce blood loss in percreta cases.
- Existing data include two RCTs and many observational studies with remaining uncertainty.
Early Postpartum Discharge Not Linked To Readmission
- Expedited postpartum discharge increased after COVID but did not raise readmission rates in a nationwide analysis.
- Outcomes depend on selection criteria and patient-reported outcomes still need study.
Use Remote BP Monitoring Postpartum
- Consider home blood pressure monitoring programs with centralized nursing for postpartum hypertensive patients.
- Such programs were associated with lower readmission, higher postpartum visit attendance, and more antihypertensive use in a large UPMC study.